| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.00B | -8.2% |
| R&D Expense | $246.8M | +29.6% |
| SG&A Expense | $763.2M | +22.9% |
| Operating Income | $139.1M | -83.5% |
| Pre-tax Income | -$29.1M | -104.0% |
| Income Tax | -$19.0M | -110.1% |
| Net Income | -$10.1M | -101.8% |
| EPS (Basic) | -$0.15 | -101.6% |
| EPS (Diluted) | -$0.15 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $118.9M | -59.4% |
| Short-term Investments | $48.4M | -7.1% |
| Accounts Receivable | $303.3M | -33.2% |
| Inventory | $577.8M | +10.2% |
| Current Assets | $1.31B | -16.8% |
| Total Assets | $8.56B | -3.3% |
| Current Liabilities | $833.8M | -17.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $280.2M | -68.3% |
| Capital Expenditures | $209.3M | +48.5% |
| Investing Cash Flow | -$187.6M | +88.6% |
| Financing Cash Flow | -$265.8M | -205.5% |
| Free Cash Flow | $70.9M | -90.5% |
| -101.6% |
| Long-term Debt |
| $2.42B |
| -8.5% |
| Total Liabilities | $3.56B | -9.3% |
| Stockholders' Equity | $5.01B | +1.4% |